Clinical Trials Browser

OTHER × Nasopharyngeal Cancinoma (NPC) × Immune Checkpoint Inhibitors × Clear all

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

Nasopharyngeal Cancinoma (NPC)